Polymorphs of GABA alpha 5 agonists and methods of use thereof in treatment of cognitive impairment
The present invention relates to crystalline forms of a GABAA a5 agonist, pharmaceutical compositions and combinations comprising those crystalline forms, their use in methods of treating cognitive impairment associated with central nervous system (CNS) disorders, cognitive impairment associated wit...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GANDRA DHARMENDRA PARENT STEPHEN D GREG BENJAMIN HOUSTON TRAVIS L HEGDE VIKRAM |
| description | The present invention relates to crystalline forms of a GABAA a5 agonist, pharmaceutical compositions and combinations comprising those crystalline forms, their use in methods of treating cognitive impairment associated with central nervous system (CNS) disorders, cognitive impairment associated with brain cancer, brain cancer itself or Parkinson's disease psychosis, and methods of producing the crystalline forms.
GABAAα5激动剂的结晶形式，包含那些结晶形式的药物组合物和组合，它们在治疗与中枢神经系统(CNS)障碍相关的认知损害、与脑癌相关的认知损害、脑癌本身或帕金森病精神病的方法中的用途，以及生产所述结晶形式的方法。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116457019A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116457019A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116457019A3</originalsourceid><addsrcrecordid>eNqNik0KwjAQRrNxIeodxgMIFq3FZSz-rMSF-zKk0ybQZEIyCt5eKx7A1ft435sqc-Ph5TlFm4E7OOuDBhyiRSgBew4uSwYMLXgSy-03emQCsZTos10ASYTiKcj4Ge6DE_ckcD6iS6Ofq0mHQ6bFjzO1PB3v9WVFkRvKEQ0Fkqa-FsVuW1brYq83_zRv_Yo9og</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Polymorphs of GABA alpha 5 agonists and methods of use thereof in treatment of cognitive impairment</title><source>esp@cenet</source><creator>GANDRA DHARMENDRA ; PARENT STEPHEN D ; GREG BENJAMIN ; HOUSTON TRAVIS L ; HEGDE VIKRAM</creator><creatorcontrib>GANDRA DHARMENDRA ; PARENT STEPHEN D ; GREG BENJAMIN ; HOUSTON TRAVIS L ; HEGDE VIKRAM</creatorcontrib><description>The present invention relates to crystalline forms of a GABAA a5 agonist, pharmaceutical compositions and combinations comprising those crystalline forms, their use in methods of treating cognitive impairment associated with central nervous system (CNS) disorders, cognitive impairment associated with brain cancer, brain cancer itself or Parkinson's disease psychosis, and methods of producing the crystalline forms.
GABAAα5激动剂的结晶形式，包含那些结晶形式的药物组合物和组合，它们在治疗与中枢神经系统(CNS)障碍相关的认知损害、与脑癌相关的认知损害、脑癌本身或帕金森病精神病的方法中的用途，以及生产所述结晶形式的方法。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230718&DB=EPODOC&CC=CN&NR=116457019A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230718&DB=EPODOC&CC=CN&NR=116457019A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GANDRA DHARMENDRA</creatorcontrib><creatorcontrib>PARENT STEPHEN D</creatorcontrib><creatorcontrib>GREG BENJAMIN</creatorcontrib><creatorcontrib>HOUSTON TRAVIS L</creatorcontrib><creatorcontrib>HEGDE VIKRAM</creatorcontrib><title>Polymorphs of GABA alpha 5 agonists and methods of use thereof in treatment of cognitive impairment</title><description>The present invention relates to crystalline forms of a GABAA a5 agonist, pharmaceutical compositions and combinations comprising those crystalline forms, their use in methods of treating cognitive impairment associated with central nervous system (CNS) disorders, cognitive impairment associated with brain cancer, brain cancer itself or Parkinson's disease psychosis, and methods of producing the crystalline forms.
GABAAα5激动剂的结晶形式，包含那些结晶形式的药物组合物和组合，它们在治疗与中枢神经系统(CNS)障碍相关的认知损害、与脑癌相关的认知损害、脑癌本身或帕金森病精神病的方法中的用途，以及生产所述结晶形式的方法。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNik0KwjAQRrNxIeodxgMIFq3FZSz-rMSF-zKk0ybQZEIyCt5eKx7A1ft435sqc-Ph5TlFm4E7OOuDBhyiRSgBew4uSwYMLXgSy-03emQCsZTos10ASYTiKcj4Ge6DE_ckcD6iS6Ofq0mHQ6bFjzO1PB3v9WVFkRvKEQ0Fkqa-FsVuW1brYq83_zRv_Yo9og</recordid><startdate>20230718</startdate><enddate>20230718</enddate><creator>GANDRA DHARMENDRA</creator><creator>PARENT STEPHEN D</creator><creator>GREG BENJAMIN</creator><creator>HOUSTON TRAVIS L</creator><creator>HEGDE VIKRAM</creator><scope>EVB</scope></search><sort><creationdate>20230718</creationdate><title>Polymorphs of GABA alpha 5 agonists and methods of use thereof in treatment of cognitive impairment</title><author>GANDRA DHARMENDRA ; PARENT STEPHEN D ; GREG BENJAMIN ; HOUSTON TRAVIS L ; HEGDE VIKRAM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116457019A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>GANDRA DHARMENDRA</creatorcontrib><creatorcontrib>PARENT STEPHEN D</creatorcontrib><creatorcontrib>GREG BENJAMIN</creatorcontrib><creatorcontrib>HOUSTON TRAVIS L</creatorcontrib><creatorcontrib>HEGDE VIKRAM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GANDRA DHARMENDRA</au><au>PARENT STEPHEN D</au><au>GREG BENJAMIN</au><au>HOUSTON TRAVIS L</au><au>HEGDE VIKRAM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Polymorphs of GABA alpha 5 agonists and methods of use thereof in treatment of cognitive impairment</title><date>2023-07-18</date><risdate>2023</risdate><abstract>The present invention relates to crystalline forms of a GABAA a5 agonist, pharmaceutical compositions and combinations comprising those crystalline forms, their use in methods of treating cognitive impairment associated with central nervous system (CNS) disorders, cognitive impairment associated with brain cancer, brain cancer itself or Parkinson's disease psychosis, and methods of producing the crystalline forms.
GABAAα5激动剂的结晶形式，包含那些结晶形式的药物组合物和组合，它们在治疗与中枢神经系统(CNS)障碍相关的认知损害、与脑癌相关的认知损害、脑癌本身或帕金森病精神病的方法中的用途，以及生产所述结晶形式的方法。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN116457019A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Polymorphs of GABA alpha 5 agonists and methods of use thereof in treatment of cognitive impairment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A14%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GANDRA%20DHARMENDRA&rft.date=2023-07-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116457019A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |